Page 32 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OLD Second National Bank of Aurora lowered its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.3% in the second quarter, Holdings Channel reports. The firm owned 3,192 shares of the biopharmaceutical company’s stock after selling 143 shares during the quarter. OLD Second National Bank of Aurora’s holdings in Regeneron Pharmaceuticals […]

Wealth Enhancement Advisory Services LLC lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 11.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,871 shares of the biopharmaceutical company’s stock after purchasing an additional 488 shares […]

North Point Portfolio Managers Corp OH lessened its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 22.2% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 17,956 shares of the biopharmaceutical company’s stock after selling 5,124 shares during the quarter. Regeneron Pharmaceuticals accounts for approximately 2.6% […]

Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target raised by Bank of America from $665.00 to $680.00 in a research report report published on Friday, FlyOnTheWall reports. Other analysts have also recently issued reports about the stock. Morgan Stanley raised their price target on shares of Regeneron Pharmaceuticals from $897.00 to $912.00 and […]

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-six analysts that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation and nineteen have given a buy recommendation to the company. […]